Market Research Logo

Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review

Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has subsidiaries in Ireland, the US, Scotland and Israel. Amarin is headquartered at Dublin, Ireland.

Amarin Corp Plc Key Recent Developments

May 02,2018: Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations
Apr 23,2018: Amarin Announces Promotes Aaron Berg To Chief Commercial Officer
Apr 04,2018: Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa Promotion Initiatives
Feb 27,2018: Amarin Reports Announces Fourth Quarter and Full Year 2017 Financial Results
Nov 01,2017: Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Amarin Corp Plc - Key Facts
Amarin Corp Plc - Key Employees
Amarin Corp Plc - Key Employee Biographies
Amarin Corp Plc - Major Products and Services
Amarin Corp Plc - History
Amarin Corp Plc - Company Statement
Amarin Corp Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amarin Corp Plc - Business Description
Product Category: Licensing Revenue
Overview
Performance
Product Category: Vascepa
Overview
Performance
R&D Overview
Amarin Corp Plc - SWOT Analysis
SWOT Analysis - Overview
Amarin Corp Plc - Strengths
Amarin Corp Plc - Weaknesses
Amarin Corp Plc - Opportunities
Amarin Corp Plc - Threats
Amarin Corp Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Amarin Corp Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 04, 2018: Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa Promotion Initiatives
Nov 01, 2017: Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations
Aug 02, 2017: Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations
May 03, 2017: Amarin reports lower Q1 net loss, re-affirms annual guidance
Feb 28, 2017: Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations
Jan 05, 2017: Amarin announces revenue forecast for 2017
Jan 05, 2017: Amarin Provides Preliminary 2016 Results and 2017 Outlook
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Amarin Corp Plc, Key Facts
Amarin Corp Plc, Key Employees
Amarin Corp Plc, Key Employee Biographies
Amarin Corp Plc, Major Products and Services
Amarin Corp Plc, History
Amarin Corp Plc, Subsidiaries
Amarin Corp Plc, Key Competitors
Amarin Corp Plc, Ratios based on current share price
Amarin Corp Plc, Annual Ratios
Amarin Corp Plc, Annual Ratios (Cont...1)
Amarin Corp Plc, Interim Ratios
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Amarin Corp Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Amarin Corp Plc, Performance Chart (2013 - 2017)
Amarin Corp Plc, Ratio Charts
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report